Page last updated: 2024-08-24

triazoles and quizartinib

triazoles has been researched along with quizartinib in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Geng, J; Li, Y; Najafov, A; Ofengeim, D; Ouchida, AT; Sun, X; Yu, Q; Yuan, J1
Cheng, T; Guo, D; Ma, X; Ren, Q; Wang, N; Yin, J; You, N; Zhang, P; Zhao, Y; Zhu, W1

Other Studies

2 other study(ies) available for triazoles and quizartinib

ArticleYear
Synergistic effect of a novel autophagy inhibitor and Quizartinib enhances cancer cell death.
    Cell death & disease, 2018, 01-26, Volume: 9, Issue:2

    Topics: Apoptosis; Autophagy; Benzothiazoles; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Humans; Neoplasms; Oxazoles; Phenylurea Compounds; Receptor, ErbB-2; Signal Transduction; Triazoles

2018
GADD45g acts as a novel tumor suppressor, and its activation suggests new combination regimens for the treatment of AML.
    Blood, 2021, 08-12, Volume: 138, Issue:6

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Azepines; Benzothiazoles; Depsipeptides; fms-Like Tyrosine Kinase 3; Gene Expression Regulation, Neoplastic; HL-60 Cells; Humans; Intracellular Signaling Peptides and Proteins; Leukemia, Myeloid, Acute; Mice; Mice, Inbred NOD; Mice, SCID; Mutation; Phenylurea Compounds; THP-1 Cells; Triazoles; Tumor Suppressor Proteins; U937 Cells; Up-Regulation

2021